Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

844
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
844
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

766
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
766
Pulse rhythm01:30

Pulse rhythm

1.3K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revisiting Insulin Resistance in the Pathophysiology of Type 2 Diabetes Mellitus: A Multi-Organ Perspective.

Diabetes & metabolism journal·2026
Same author

Engaging Stakeholders to Define Research Priorities and Build a Research Community to Reduce Obesity Among Hispanic Women in the Southeastern United States.

Journal of racial and ethnic health disparities·2026
Same author

Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance.

Circulation. Population health and outcomes·2026
Same author

Foods to Prevent Cardiometabolic Disease: Moving from "Saturated Fat" to "Whole Foods".

Current developments in nutrition·2026
Same author

Challenges of using AI-based synthetic data in health economics and outcomes research.

Expert review of pharmacoeconomics & outcomes research·2026
Same author

Vaccine uptake in the context of mandate announcement and removal: Evidence from Europe and North America.

Vaccine·2026

Related Experiment Video

Updated: Jan 8, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

7.5K

Important Continuous Glucose Monitoring Attributes for Patients With Type 2 Diabetes.

Tim C Lai1, Heather P Whitley2, Mesfin Genie3,4

  • 1Department of Health Outcomes Research and Policy, Auburn University Harrison College of Pharmacy, Auburn, AL.

Clinical Diabetes : a Publication of the American Diabetes Association
|December 24, 2025
PubMed
Summary

For type 2 diabetes patients, out-of-pocket cost and accuracy are key factors when selecting continuous glucose monitoring (CGM) systems. Receiver screen information is less important, but education on its interpretation could improve CGM benefits.

More Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.3K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

71.2K

Related Experiment Videos

Last Updated: Jan 8, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

7.5K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.3K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

71.2K

Area of Science:

  • Endocrinology
  • Medical Devices
  • Patient-Reported Outcomes

Background:

  • Continuous glucose monitoring (CGM) is crucial for managing type 2 diabetes.
  • Patient preferences significantly influence the adoption and adherence to diabetes technology.
  • Understanding key decision-making factors for CGM systems is essential for effective patient care.

Purpose of the Study:

  • To identify the most important attributes influencing patient choice of continuous glucose monitoring (CGM) systems.
  • To explore the role of receiver screen information in CGM system selection.
  • To inform strategies for improving patient-provider communication and CGM adherence.

Main Methods:

  • Survey-based study assessing patient preferences for CGM attributes.
  • Analysis of attribute importance ratings among patients with type 2 diabetes.
  • Qualitative or quantitative assessment of factors influencing CGM system choice.

Main Results:

  • Out-of-pocket cost and system accuracy were identified as the primary drivers for CGM selection.
  • Receiver screen information was surprisingly deemed unimportant by patients when choosing a CGM system.
  • Patient preferences for CGM systems are heterogeneous but center on cost and accuracy.

Conclusions:

  • Focusing on cost and accuracy in patient education and system design can enhance CGM adoption for type 2 diabetes.
  • Improving patient understanding of CGM receiver screen data may increase the overall utility and benefits of the technology.
  • Tailoring CGM system recommendations to patient priorities is vital for optimizing diabetes management and adherence.